Company: QTIWW
Filing Date: 2025-12-31
Form Type: 424B3
Source: 0001628280-25-059235
Chunk: 121

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-12-31
Form: 424B3
Chunk 121
---
.

Our ability to make distributions, loans and other payments for the purposes described above and for any other purpose may be limited by credit agreements to which the Company is party from time to time, including the existing Credit Agreement with Lynrock Lake, and will be subject to the negative covenants set forth therein. Any loans or other extensions of credit to QT Imaging from the Company will be permitted only to the extent there is an applicable exception to the investment covenants under this loan agreement. Similarly, any dividends, distributions or similar payments to QT Imaging from the Company will be permitted only to the extent there is an applicable exception to the dividends and distributions covenants under this loan agreement.

<div align='center'>72</div>

### USE OF PROCEEDS
All of the Common Stock offered by the Selling Securityholders pursuant to this prospectus will be sold by the Selling Securityholders for their respective accounts. We will not receive any of the proceeds from these sales. With respect to the Warrants, we will not receive any proceeds from such shares except with respect to amounts received by us upon exercise of the warrants to the extent such Warrants are exercised for cash. We intend to use any such proceeds for working capital and general corporate purposes.

The Selling Securityholders will pay any underwriting fees, discounts, selling commissions, stock transfer taxes and certain legal expenses incurred by such Selling Securityholders in disposing of the shares of Common Stock, and we will bear all other costs, fees, and expenses incurred in effecting the registration of the securities covered by this prospectus, including, without limitation, all registration and filing fees, Nasdaq listing fees and fees and expenses of our counsel and out independent registered public accountants.

However, we have received $500,000 aggregate gross proceeds from the sales we made to the First Purchasers pursuant to the First Securities Purchase Agreement, $200,000 aggregate gross proceeds from the sales we made to the Second Purchaser pursuant to the Second Securities Purchase Agreement and $18,180,655 aggregate gross proceeds from the sales we made to the Third Purchasers pursuant to the Third Securities Purchase Agreement. We intend to use any such proceeds for working capital and general corporate purposes.

We will receive up to an aggregate of approximately $229,982 from the exercise of the Recanati Warrant, $1,130,298 from the exercise of the Ten Year Common Warrants, $18,181,224 from the exercise of the Subscription Warrants, $542 from the exercise of the Pre-Funded Warrants and $